Myriad Reports 37 Percent Revenue Growth for Q2 | GenomeWeb

NEW YORK (GenomeWeb News) – Myriad Genetics reported on Tuesday a 37 percent increase in fiscal year 2014 second quarter revenues compared to the year-ago period.

For the three months ended Dec. 31, 2013, the company brought in total revenues of $204.1 million, up from $149.1 million in the second quarter of 2013, and above analysts' consensus estimate of $176 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.